Why Psychedelic Delivery Mechanisms Matter
October 2, 2020
Ryan Allway October 2nd, 2020 App, Exclusive, News, Psychedelics, Top News The psychedelics industry is poised to become a nearly $7 billion market by 2027, according to Data Bridge Market Research, driven by the potential to revolutionize the treatment of mental health disorders. While investors have many options in... Read more
Ayr Strategies Enters into Agreements to Expand Operations to Fourth State with Strategic Acquisitions in Ohio; Deepens Pennsylvania Presence
October 2, 2020
Ryan Allway October 2nd, 2020 News, Top News Acquisitions Further Position Ayr to Become a Top-Tier MSO TORONTO, Oct. 01, 2020 (GLOBE NEWSWIRE) — Ayr Strategies (CSE: AYR.A, OTCQX: AYRSF, “Ayr” or “the Company”), a leading vertically integrated cannabis multi-state operator, today announced the addition of cultivation and processing... Read more
Building a Cannabis Conglomerate
October 1, 2020
Ryan Allway October 1st, 2020 App, Exclusive, News, Top News Investors don’t have to look hard to find conglomerates in the alcoholic beverage industry—a close proxy for the recreational cannabis industry. AB InBev (NYSE: BUD) generates about $50 billion per year in sales with more than 400 beer brands... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Pure Extract Technologies Inc. Receives Health Canada Standard Processing License
September 30, 2020
Vancouver, B.C., September 30, 2020 – Big Sky Petroleum Corporation (TSX-V: BSP.H) (“Big Sky”) and Pure Extract Technologies Inc. (“Pure Extracts”) are pleased to announce that further to the Big Sky news release dated February 19, 2020 announcing its proposed acquisition (the “Proposed Transaction”) of Pure Extracts, pursuant to which Big... Read more
Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today
September 30, 2020
Ryan Allway September 30th, 2020 App, News, Top News DENVER, Colorado, USA – September 30th, 2020 – Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital telehealth mobile application for mental coaching and wellbeing, has... Read more
Aleafia Health Launches Cannabis 2.0 Portfolio with 510 Vape Cartridges Featuring Unique Formulations
September 29, 2020
For Investor & Media Relations: Nicholas Bergamini, VP Investor Relations1-833-879-2533LEARN MORE: www.AleafiaHealth.com About Aleafia Health: Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production... Read more
Hyasynth first to market with CBD in global race to commercialize cannabinoids produced using microbial biosynthesis
September 29, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
September 28, 2020 (Source) — Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce... Read more
Cardiol Therarpeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III COVID-19 Trial
CBD September 25, 2020
Ryan Allway September 25th, 2020 News, Top News Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease (CVD) Oakville, Ontario–(Newsfile Corp. – September 25, 2020) – Cardiol... Read more
